Abstract
The potentiating effects of cyanide on the inhibition of rat liver mitochondrial monoamine oxidase-A & B and of ox liver mitochondrial MAO-B by pheniprazine [(1-methyl-2-phenylethyl)hydrazine] has been studied. Pheniprazine was shown to behave as a mechanism-based MAO inhibitor. For rat liver MAO-B, the initial non-covalent step was characterized by dissociation constant (K i) of 2450 nM and the first-order rate constant (k +2) for the covalent adduct formation was 0.16 min−1. As a reversible inhibitor it was selective towards rat liver MAO-A (K i = 420 nM) but the rate of irreversible inhibition of that enzyme was considerably slower (k +2 = 0.06 min−1). MAO-B from ox liver more closely resembled MAO-A from the rat in sensitivity to reversible inhibition by pheniprazine (K i = 450 nm) but it was closer to rat liver MAO-B in rate of irreversible inhibition (k +2 = 0.29 min−1). The K i values were significantly decreased in the presence of KCN but there was little effect on the k +2 values. However, sensitivities of the different enzymes to KCN varied widely and considerably higher concentrations of KCN were required for this effect to be apparent with the rat liver mitochondrial MAO-A than with MAO-B from rat and ox liver. The kinetic behaviour of cyanide activation was consistent with partial (non-essential) competitive activation in all cases.
Similar content being viewed by others
References
Tipton KF (1989) Monoamine oxidase inhibitors as antidepressants. In: Tipton KF, Youdim MBH (eds) Biochemical and pharmacological aspects of depression. Taylor & Francis, London, pp 1–24
Patek DR, Hellerman L (1974) Mitochondrial monoamine oxidase: mechanism of inhibition by phenylhydrazine and aralkylhydrazine. Role of enzymatic oxidation. J Biol Chem 249:2373–2380
Kenny WC, Nagy J, Salach JI, Singer TP (1979). Structure of the covalent phenylhydrazine adduct of monoamine oxidase. In: Singer TP, von Korff RW, Murphy DL (eds) Monoamine oxidase: Structure, function and altered functions. Academic Press, New York, pp 1–24
Davison AN (1957) The mechanism of the irreversible inhibition of rat liver monoamine oxidase by iproniazid (Marsilid). Biochem J 67:316–322
Ben Ramadan Z, Dostert P, Tipton KF (1999) Some peculiar aspects of monoamine oxidase inhibition. Neurobiology 7:159–174
Houslay MD, Tipton KF (1973) The reaction pathway of rat liver monoamine oxidase. Biochem J 135:173–186
Tipton KF, Spires IPC (1972). The kinetics of phenethylhydrazine oxidation by monoamine oxidase. Biochem J 125:521–524
Yu PH, Tipton KF (1989). Deuterium isotope effect of phenelzine on the inhibition of rat liver mitochondrial monoamine oxidase activity. Biochem Pharmacol 38:4245–4251
Salach JI (1979) Monoamine oxidase from beef liver mitochondria: simplified isolation procedure, properties and determination of its cysteinyl flavin content Arch. Biochem Biophys 192:128–137
Tipton KF, Davey GP, Motherway M (2000) Monoamine oxidase assays. In: Enna SJ, Willias M, Ferkany JW, Kenakin T, Porsolt RE, Sullivan JP (eds) Current protocols in pharmacology. John Wiley, New York, pp 3.6.1–3.6.42
Tian WX, Tsou CL (1982) Determination of the rate constant of enzyme modification by measuring the substrate reaction in the presence of the modifier. Biochemistry 21:1028–1032
Tipton KF (2001) Enzymes: Irreversible inhibition. Encyclopedia of life sciences. http://www.els.net/[doi:10.1038/npg.els.0000601], John Wiley, New York
Tipton KF (2003) Enzyme activities. In: Davey J, Lord JM (eds) Essential cell biology: Cell function, vol. 2 (practical approach). Oxford University Press, pp 1–46
Walsh CT (1982) Suicide substrates: Mechanism-based enzyme inactivators. Tetrahedron 38:871–909
Fowler CJ, Mantle TJ, Tipton KF (1982) The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline. Biochem Pharmacol 31:3555–3561
Garrick NA, Murphy DL (1982) Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain. Psychopharmacology 72:27–33
Reid AA, Hill JL, Murphy DL (1988) Interactions of tricyclic antidepressant drugs with human and rat monoamine oxidase type B. Naunyn-Schmiedeberg’s Arch Pharmacol 388:678–683
Krueger MJ, Mazouz F, Ramsay RR, Milcent R, Singer TP (1995) Dramatic species differences in the susceptibility of monoamine oxidase B to a group of powerful inhibitors. Biochem Biophys Res Commun 206:556–562
O’Brien EM, Dostert P, Tipton KF (1995) Species differences in the interactions of the anticonvulsant milacemide and some analogues with monoamine oxidase-B. Biochem Pharmacol 50:317–324
Hubalek F, Binda C, Khalil A, Li M, Mattevi A, Castagnoli N, Edmondson DE (2005). Demonstration of isoleucine 199 as a structural determinant for the selective inhibition of human monoamine oxidase B by specific reversible inhibitors. J Biol Chem 280:15761–15766
Hubalek F, Pohl J, Edmondson DE (2003) Structural comparison of human monoamine oxidases A and B. Mass spectrometry monitoring of cysteine reactivities. J Biol Chem 278:28612–28618
Kenney WC, Nagy J, Salach JI, Singer TP (1979) Structure of the covalent phenylhydrazine adduct of monoamine oxidase. In: Singer TP, Von Korff RW, Murphy DL (eds) Monoamine oxidase: Structure, function and altered functions. Academic Press, New York, pp 25–37
Valley MP, Tichy SE, Fitzpatrick PF (2005) Establishing the kinetic competency of the cationic imine intermediate in nitroalkane oxidase. J Am Chem Soc 127:2062–2066
Acknowledgments
We are grateful to the Health Research Board and Forbairt, Ireland, for support for this work, to the Government of Libya for a grant in support of ZBR and to the EC ERASMUS Programme for the support of MLW.
Author information
Authors and Affiliations
Corresponding author
Additional information
Special issue dedicated to Dr. Moussa Youdim.
Rights and permissions
About this article
Cite this article
Ramadan, Z.B., Wrang, M.L. & Tipton, K.F. Species Differences in the Selective Inhibition of Monoamine Oxidase (1-methyl-2-phenylethyl)hydrazine and its Potentiation by Cyanide. Neurochem Res 32, 1783–1790 (2007). https://doi.org/10.1007/s11064-007-9309-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-007-9309-x